Login / Signup

Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?

Matthew GallittoKunal SindhuIsaac WassermanBrian DeVishal GuptaBrett A MilesEric M GendenMarshall PosnerKrzysztof MisiukiewiczRichard L Bakst
Published in: Head & neck (2019)
Surgery for OPC offers the potential for reduction in radiation volumes by omitting the contralateral neck in those who may have required definitive chemoradiation. Even in patients receiving concurrent chemotherapy, unilateral neck radiation has a favorable toxicity profile without compromising survival.
Keyphrases